A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2

Traffic

Volumn 16, Issue 12, 2015, Pages 1270-1287

  Selyunin, Andrey S ^a   Mukhopadhyay, Somshuvra ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Bacterial toxin; Endosome; Golgi; Protein motif; Trafficking

Indexed keywords

CELL RECEPTOR; DYNAMIN II; ENDOSOMAL RECEPTOR; EPSIN; EPSIN R; MEMBRANE PROTEIN; RETROMER; SHIGA TOXIN; SHIGA TOXIN TYPE 1B; SHIGA TOXIN TYPE 2B; SYNTAXIN; SYNTAXIN 5; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2; GALACTOSYLTRANSFERASE; GOLIM4 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN SUBUNIT; SHIGA TOXIN 2 B SUBUNIT; UDP-GALACTOSE-LACTOSYLCERAMIDE ALPHA 1-4-GALACTOSYLTRANSFERASE; VESICULAR TRANSPORT PROTEIN;

ARTICLE; BETA CHAIN; CELL MIGRATION; CELL SELECTION; CELL SURFACE; CONTROLLED STUDY; ENDOSOME; FEMALE; GOLGI COMPLEX; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PROTEOMICS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SIGNAL TRANSDUCTION; CHEMISTRY; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; GENETICS; KINETICS; METABOLISM; MOLECULAR EVOLUTION; PROTEIN SUBUNIT;

AMINO ACID MOTIFS; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; ENDOSOMES; EVOLUTION, MOLECULAR; GALACTOSYLTRANSFERASES; GOLGI APPARATUS; HELA CELLS; HUMANS; KINETICS; PROTEIN BINDING; PROTEIN SUBUNITS; PROTEIN TRANSPORT; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VESICULAR TRANSPORT PROTEINS;

EID: 84955182965     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12338     Document Type: Article

References (46)

1. 5 toxins: mechanisms to therapeutics. J Mol Med 2013;91:1131-1141.
2. Beddoe T, Paton AW, Le Nours J, Rossjohn J, Paton JC. Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci 2010;35:411-418.
3. Strockbine NA, Jackson MP, Sung LM, Holmes RK, O'Brien AD. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol 1988;170:1116-1122.
4. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999;77:651-666.
5. Nataro JP, Pickering LK. Diarrheagenic Escherichia Coli. In: McMillan JA, Feigin RD, DeAngelis C, Jones MD Jr, editors. Oski's Paediatrics: Principles and Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2006, pp. 1063-1068.
6. Mohawk KL, O'Brien AD. Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol 2011;2011:258185.
7. Ochoa TJ, Cleary TG. Shigellosis. In: McMillan JA, Feigin RD, DeAngelis C, Jones MD Jr, editors. Oski's Paediatrics: Principle and Practice. Philadelphia, PA: Lippincott, Williams & Wilkins; 2006, pp. 1116-1120.
8. Matsushiro A, Sato K, Miyamoto H, Yamamura T, Honda T. Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol 1999;181:2257-2260.
9. McGannon CM, Fuller CA, Weiss AA. Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother 2010;54:3790-3798.
10. Walterspiel JN, Ashkenazi S, Morrow AL, Cleary TG. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 1992;20:25-29.
11. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000;181:664-670.
12. Mukhopadhyay S, Linstedt AD. Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 2012;335:332-335.
13. Saenz JB, Doggett TA, Haslam DB. Identification and characterization of small molecules that inhibit intracellular toxin transport. Infect Immun 2007;75:4552-4561.
14. Stechmann B, Bai SK, Gobbo E, Lopez R, Merer G, Pinchard S, Panigai L, Tenza D, Raposo G, Beaumelle B, Sauvaire D, Gillet D, Johannes L, Barbier J. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 2010;141:231-242.
15. Johannes L, Popoff V. Tracing the retrograde route in protein trafficking. Cell 2008;135:1175-1187.
16. Sandvig K, van Deurs B. Membrane traffic exploited by protein toxins. Annu Rev Cell Dev Biol 2002;18:1-24.
17. Mallard F, Antony C, Tenza D, Salamero J, Goud B, Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol 1998;143:973-990.
18. Mukhopadhyay S, Redler B, Linstedt AD. Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms. Mol Biol Cell 2013;24:2311-2318.
19. Natarajan R, Linstedt AD. A cycling cis-Golgi protein mediates endosome-to-Golgi traffic. Mol Biol Cell 2004;15:4798-4806.
20. Bachert C, Lee TH, Linstedt AD. Lumenal endosomal and Golgi-retrieval determinants involved in pH-sensitive targeting of an early Golgi protein. Mol Biol Cell 2001;12:3152-3160.
21. Linstedt AD, Mehta A, Suhan J, Reggio H, Hauri HP. Sequence and overexpression of GPP130/GIMPc: evidence for saturable pH-sensitive targeting of a type II early Golgi membrane protein. Mol Biol Cell 1997;8:1073-1087.
22. Mukhopadhyay S, Bachert C, Smith DR, Linstedt AD. Manganese-induced trafficking and turnover of the cis-Golgi glycoprotein GPP130. Mol Biol Cell 2010;21:1282-1292.
23. Mukhopadhyay S, Linstedt AD. Identification of a gain-of-function mutation in a Golgi P-type ATPase that enhances Mn2+ efflux and protects against toxicity. Proc Natl Acad Sci U S A 2011;108:858-863.
24. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, O'Brien AD, Samuel JE. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 1993;61:3392-3402.
25. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 1999;37:497-503.
26. Lauvrak SU, Torgersen ML, Sandvig K. Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin. J Cell Sci 2004;117:2321-2331.
27. Popoff V, Mardones GA, Tenza D, Rojas R, Lamaze C, Bonifacino JS, Raposo G, Johannes L. The retromer complex and clathrin define an early endosomal retrograde exit site. J Cell Sci 2007;120:2022-2031.
28. Saint-Pol A, Yelamos B, Amessou M, Mills IG, Dugast M, Tenza D, Schu P, Antony C, McMahon HT, Lamaze C, Johannes L. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev Cell 2004;6:525-538.
29. Tai G, Lu L, Wang TL, Tang BL, Goud B, Johannes L, Hong W. Participation of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex in transport from the early/recycling endosome to the trans-Golgi network. Mol Biol Cell 2004;15:4011-4022.
30. Amessou M, Fradagrada A, Falguieres T, Lord JM, Smith DC, Roberts LM, Lamaze C, Johannes L. Syntaxin 16 and syntaxin 5 are required for efficient retrograde transport of several exogenous and endogenous cargo proteins. J Cell Sci 2007;120:1457-1468.
31. Chavrier P, Parton RG, Hauri HP, Simons K, Zerial M. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 1990;62:317-329.
32. Ullrich O, Reinsch S, Urbe S, Zerial M, Parton RG. Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol 1996;135:913-924.
33. Stenmark H, Parton RG, Steele-Mortimer O, Lutcke A, Gruenberg J, Zerial M. Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 1994;13:1287-1296.
34. Bujny MV, Popoff V, Johannes L, Cullen PJ. The retromer component sorting nexin-1 is required for efficient retrograde transport of Shiga toxin from early endosome to the trans Golgi network. J Cell Sci 2007;120:2010-2021.
35. Popoff V, Mardones GA, Bai SK, Chambon V, Tenza D, Burgos PV, Shi A, Benaroch P, Urbe S, Lamaze C, Grant BD, Raposo G, Johannes L. Analysis of articulation between clathrin and retromer in retrograde sorting on early endosomes. Traffic 2009;10:1868-1880.
36. Seaman MN. Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol 2004;165:111-122.
37. Xu Y, Martin S, James DE, Hong W. GS15 forms a SNARE complex with syntaxin 5, GS28, and Ykt6 and is implicated in traffic in the early cisternae of the Golgi apparatus. Mol Biol Cell 2002;13:3493-3507.
38. Fraser ME, Fujinaga M, Cherney MM, Melton-Celsa AR, Twiddy EM, O'Brien AD, James MN. Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem 2004;279:27511-27517.
39. Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: a key to lysosome biogenesis. Mol Biol Cell 2000;11:467-480.
40. Tam P, Mahfoud R, Nutikka A, Khine AA, Binnington B, Paroutis P, Lingwood C. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J Cell Physiol 2008;216:750-763.
41. Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 2012;13:75-88.
42. Chen W, Feng Y, Chen D, Wandinger-Ness A. Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. Mol Biol Cell 1998;9:3241-3257.
43. Hirst J, Motley A, Harasaki K, Peak Chew SY, Robinson MS. EpsinR: an ENTH domain-containing protein that interacts with AP-1. Mol Biol Cell 2003;14:625-641.
44. Willett R, Kudlyk T, Pokrovskaya I, Schonherr R, Ungar D, Duden R, Lupashin V. COG complexes form spatial landmarks for distinct SNARE complexes. Nat Commun 2013;4:1553.
45. Yamaji T, Nishikawa K, Hanada K. Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis. J Biol Chem 2010;285:35505-35518.
46. Leyva-Illades D, Chen P, Zogzas CE, Hutchens S, Mercado JM, Swaim CD, Morrisett RA, Bowman AB, Aschner M, Mukhopadhyay S. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J Neurosci 2014;34:14079-14095.